Inovio Pharmaceuticals In...

NASDAQ: INO · Real-Time Price · USD
1.86
0.24 (14.81%)
At close: Aug 15, 2025, 3:59 PM
1.89
1.61%
After-hours: Aug 15, 2025, 07:53 PM EDT

Inovio Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.46 -1 -1.33 -42.32
PEG Ratio
0.01 0.02 -0.00 -1.29
PS Ratio
228.26 163.10 36.27 7.24K
PB Ratio
0.73 1.16 1.67 32.16
P/FCF Ratio
-0.48 -1.09 -1.71 -59.24
P/OCF Ratio
-0.48 -1.09 -1.72 -59.58
OCF/S Ratio
-477.95 -149.48 -21.07 -121.54
Debt / Equity Ratio
0.17 0.26 0.14 0.08
Quick Ratio
2.77 3.60 3.25 6.82
Current Ratio
2.77 3.60 3.25 6.82
Asset Turnover
0.00 0.00 0.03 0.00
Interest Coverage
-632.05 -117.71 -213.38 -155.55
Return on Equity
-1.57 -1.15 -1.26 -0.76
Return on Assets
-0.95 -0.79 -0.8 -0.61
Return on Invested Capital
n/a -0.98 -1.05 -0.69
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-13.37 -3.21 0.46 -1.67
Net Profit Margin
-492.54 -162.4 -27.27 -171.1
Pretax Profit Margin
-492.54K -162.4 -27.06 -170.85
Operating Profit Margin
-516.17 -173 -26.07 -169.72
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-477.35 -156.72 -26.4 -167.1